214 related articles for article (PubMed ID: 36481299)
1. Midterm safety and efficacy of elective drug-coated balloon angioplasty in comparison to drug-eluting stents for unrestrictive de novo coronary lesions: A single center retrospective study.
Yamada K; Ishikawa T; Nakamura H; Mizutani Y; Ukaji T; Shimura M; Kondo Y; Aoki H; Hisauchi I; Itabashi Y; Nakahara S; Kobayashi S; Taguchi I
J Cardiol; 2023 Jun; 81(6):537-543. PubMed ID: 36481299
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Angiographic Outcomes of Elective Paclitaxel-Coated Balloon Angioplasty in Comparison with Drug-Eluting Stents for De Novo Coronary Lesions in Large Vessels.
Nakamura H; Ishikawa T; Mizutani Y; Yamada K; Ukaji T; Kondo Y; Shimura M; Aoki H; Hisauchi I; Itabashi Y; Nakahara S; Kobayashi S; Taguchi I
Int Heart J; 2023; 64(2):145-153. PubMed ID: 37005310
[TBL] [Abstract][Full Text] [Related]
3. A Propensity Score-Matched Comparison of Midterm Outcomes Between Drug-Coated Balloons and Drug-Eluting Stents for Patients with Acute Coronary Syndrome.
Mizutani Y; Ishikawa T; Nakamura H; Yamada K; Shimura M; Kondo Y; Ukaji T; Aoki H; Hisauchi I; Itabashi Y; Nakahara S; Taguchi I
Int Heart J; 2022 Mar; 63(2):217-225. PubMed ID: 35185090
[TBL] [Abstract][Full Text] [Related]
4. Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients.
Funayama N; Muratsubaki S; Ito R; Tobisawa T; Konishi T
Heart Vessels; 2023 Mar; 38(3):300-308. PubMed ID: 36045267
[TBL] [Abstract][Full Text] [Related]
5. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
Yu X; Wang X; Ji F; Zhang W; Yang C; Xu F; Wang F
Cardiovasc Drugs Ther; 2022 Aug; 36(4):655-664. PubMed ID: 33713211
[TBL] [Abstract][Full Text] [Related]
6. Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery.
Gitto M; Sticchi A; Chiarito M; Novelli L; Leone PP; Mincione G; Oliva A; Condello F; Rossi ML; Regazzoli D; Gasparini G; Cozzi O; Stefanini GG; Condorelli G; Reimers B; Mangieri A; Colombo A
Circ Cardiovasc Interv; 2023 Dec; 16(12):e013232. PubMed ID: 37874646
[TBL] [Abstract][Full Text] [Related]
7. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
[TBL] [Abstract][Full Text] [Related]
8. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
[TBL] [Abstract][Full Text] [Related]
9. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
11. Comparison of angiographic change in side-branch ostium after drug-coated balloon vs. drug-eluting stent vs. medication for the treatment of de novo coronary bifurcation lesions.
Her AY; Kim B; Kim S; Kim YH; Scheller B; Shin ES
Eur J Med Res; 2024 May; 29(1):280. PubMed ID: 38735968
[TBL] [Abstract][Full Text] [Related]
12. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
Xi Y; Chen J; Bi Y; Xie S; Liao T; Zhang Y; Kislauskis E; Wu T; Laham R; Xiao J
Catheter Cardiovasc Interv; 2020 Aug; 96(2):E129-E141. PubMed ID: 31714010
[TBL] [Abstract][Full Text] [Related]
14. Impact of Late Lumen Loss on Clinical Outcomes of Side-Branch Bifurcation Lesions Treated by Drug-Coated Balloon Angioplasty With Main-Branch Stenting.
Ikuta A; Kubo S; Ohya M; Tada T; Tanaka H; Fuku Y; Kadota K
Cardiovasc Revasc Med; 2022 Aug; 41():92-98. PubMed ID: 34973930
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease.
Merinopoulos I; Gunawardena T; Corballis N; Tsampasian V; Vassiliou V; Eccleshall S; Ryding A; Xydopoulos G
Catheter Cardiovasc Interv; 2023 Nov; 102(6):987-996. PubMed ID: 37925618
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials.
Koch T; Cassese S; Xhepa E; Mayer K; Tölg R; Hoppmann P; Laugwitz KL; Byrne RA; Kastrati A; Kufner S
Catheter Cardiovasc Interv; 2020 Nov; 96(5):1008-1015. PubMed ID: 31789486
[TBL] [Abstract][Full Text] [Related]
17. Predictors of late lumen enlargement after drug-coated balloon angioplasty for de novo coronary lesions.
Yamamoto M; Hara H; Kubota S; Hiroi Y
EuroIntervention; 2024 May; 20(9):602-612. PubMed ID: 38726721
[TBL] [Abstract][Full Text] [Related]
18. Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design.
Gao C; He X; Liu Y; Liu J; Jiang Z; Zhu B; Qin X; Xia Y; Zhang T; Wang P; Zhang R; Onuma Y; Xia J; Wang D; Serruys P; Tao L
BMC Cardiovasc Disord; 2024 Jun; 24(1):319. PubMed ID: 38914951
[TBL] [Abstract][Full Text] [Related]
19. Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
Sanz Sánchez J; Chiarito M; Cortese B; Moretti A; Pagnotta P; Reimers B; Stefanini GG; Ferrante G
Catheter Cardiovasc Interv; 2021 Jul; 98(1):66-75. PubMed ID: 32592437
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions.
Venetsanos D; Lawesson SS; Panayi G; Tödt T; Berglund U; Swahn E; Alfredsson J
Catheter Cardiovasc Interv; 2018 Nov; 92(5):E317-E326. PubMed ID: 29481718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
